Faculty Opinions recommendation of Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ).
2018 ◽
Vol 178
(5)
◽
pp. 1083-1101
◽
Keyword(s):
Keyword(s):
Keyword(s):
2007 ◽
Vol 57
(6)
◽
pp. 501
Keyword(s):